Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1-2 Study of Injection of Melphalan Into the Ophthalmic Artery in Children With Retinoblastoma

NCT00906113 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT00906113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00906113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1-2 Study of Injection of Melphalan Into the Ophthalmic Artery in Children With Retinoblastoma
Lead sponsor
Hadassah Medical Organization
Phase
Phase 1/2
Overall status
Unknown status
Start date
June 30, 2011
Completion date
December 31, 2017
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

retinoblastoma